Divi’s Laboratories Limited - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Distribution Solutions Group (DSGR) closes $145m Winzer acquisition as $35 take-private deal remains pending

Infographic showing Cizzle Brands’ approved 1-for-25 share consolidation, highlighting its U.S. exchange listing plans, proposed American offering, debt restructuring, and investor concerns over dilution, liquidity and sports nutrition growth.

Cizzle Brands moves closer to U.S. listing with 1-for-25 reverse split, but what happens to shareholder value?

Infographic highlighting Fujifilm’s instax mini Evo 2 premium instant camera, featuring a larger touchscreen, wider framing preview, short-video capture and a planned late-November North American launch.

Fujifilm instax mini Evo 2 release date, price and features: What changes from the original camera?

Infographic showing Cowboy Space’s Big Iron rocket, highlighting its 86-metre reusable-booster design, payload capacity of more than 15,000 kilograms to sun-synchronous orbit, and concept for turning the upper stage into a megawatt-class AI data centre.

Cowboy Space opens Big Iron Express launch services as 2028 orbital data-centre mission approaches

Representative image: Divi’s Laboratories’ pharma manufacturing strength remains in focus as Q4 FY2026 profit growth, margin pressure, dividend payout and #DIVISLAB valuation trends keep investors watching India’s API and custom synthesis sector.

Read More

Pharma Industry News

Is Divi’s Laboratories still worth its premium after a steady Q4 profit beat?

Divi’s Laboratories posted Q4 profit growth and a ₹30 dividend, but margin pressure keeps valuation in focus. Read what #DIVISLAB signals now!

byPallavi Madhiraju

May 25, 2026

web analytics